PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses

First line anti-viral protein rendered ineffective by Amphotericin B

2013-11-21
(Press-News.org) Contact information: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses First line anti-viral protein rendered ineffective by Amphotericin B WORCESTER, MA – Scientists at the University of Massachusetts Medical School (UMMS) and the Wellcome Trust Sanger Institute have discovered evidence that a widely used anti-fungal medicine increases susceptibility to flu infection in mice and cell cultures. Published online in Cell Reports, the study shows that Amphotericin B, commonly given to cancer and bone marrow transplant patients to fight invasive fungal infections, neutralizes an important anti-viral protein, making it easier for viruses to infect cells.

These findings suggest that patients taking the antifungal therapy may be functionally immunocompromised and vulnerable to influenza and potentially other viruses.

"While these studies don't confirm that such an interaction may translate into clinical relevance for patients, it does suggest that some vigilance is warranted, especially for patients who are undergoing treatment for cancer and may already have suppressed immune systems," said Abraham Brass, MD, PhD, assistant professor of microbiology & physiological systems and senior author of the study.

Paul Kellam, PhD, professor from the Wellcome Trust Sanger Institute and co-author of the study said, "This is an important discovery and the consequences for patients on certain anti-fungal treatments should now be investigated. Preventative flu vaccinations, rapid antiviral therapy or alternative anti-fungal treatment could be offered to these patients when at risk of flu infection."

Found in nearly all human cells, IFITM3 works to alter the cell membrane, making it more difficult for viruses, such as the influenza virus, to penetrate the cell's outer layer. When IFITM3 is inactive, influenza viruses can more readily infiltrate and infect the cell. Previous studies by Drs. Kellam and Brass and their colleagues have also shown that people who have a genetic variant in the IFITM3 gene are more susceptible to influenza.

Brass and his lab were working to understand how IFITM3 protects cells from viral infection when they discovered the link between Amphotericin B and influenza. "Several cell cultures in the lab became contaminated with a fungus," said Brass. "We treated them with Amphotericin B, not knowing it would have an effect on IFITM3 activity. Surprisingly, when we tested for influenza infection we found no IFITM3 activity in the normal, wild type, cells. At that point, we began to suspect that Amphotericin B was having an effect on IFITM3."

This unexpected revelation opened up a new line of inquiry that revealed that Amphotericin B was preventing IFITM3 from fending off the influenza virus. "When we treated lung cancer cells with the anti-fungal drug, we saw the anti-viral protection normally provided by IFITM3 disappear," said Christopher R. Chin, research associate in the Brass lab and co-first author of the study.

To better appreciate the effects Amphotericin B has on IFITM3, Brass teamed up with Kellam to treat mice with the anti-fungal drug. The pair found that once the mice contracted influenza, they displayed the same, more severe flu symptoms as mice completely lacking the protective IFITM3 gene. In the absence of the influenza virus, the mice treated with the Amphotericin B showed no signs of illness.

This research indicates that patients undergoing Amphotericin B anti-fungal treatments could potentially lose the protective effects of IFITM3, increasing the risk of flu infections in patients with already compromised immune systems.

"Sometimes a very useful drug can also have unforeseen effects," said Brass. "We now see that a major part of the body's natural defenses to influenza virus is rendered inactive by Amphotericin B in cells and mice. It's our hope that reporting the consequences of this interaction may stimulate further translational studies and potentially guide patient care."

Both Kellam and Brass agree that further work is now needed to evaluate if this effect has any clinical significance for patients receiving Amphotericin B-based treatments.

INFORMATION:

This research was part of an ongoing collaboration between institutes in the United States (UMass Medical School) and the United Kingdom (Wellcome Trust Sanger Institute).

About the University of Massachusetts Medical School

The University of Massachusetts Medical School (UMMS), one of five campuses of the University system, is comprised of the School of Medicine, the Graduate School of Biomedical Sciences, the Graduate School of Nursing, a thriving research enterprise and an innovative public service initiative, Commonwealth Medicine. Its mission is to advance the health of the people of the Commonwealth through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education. The Medical School attracts more than $240 million annually in research funding, placing it among the top 50 medical schools in the nation. In 2006, UMMS's Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator and the Blais University Chair in Molecular Medicine, was awarded the Nobel Prize in Physiology or Medicine, along with colleague Andrew Z. Fire, PhD, of Stanford University, for their discoveries related to RNA interference (RNAi). The 2013 opening of the Albert Sherman Center ushered in a new era of biomedical research and education on campus. Designed to maximize collaboration across fields, the Sherman Center is home to scientists pursuing novel research in emerging scientific fields with the goal of translating new discoveries into innovative therapies for human diseases.

END



ELSE PRESS RELEASES FROM THIS DATE:

UCLA first to map autism-risk genes by function

2013-11-21
UCLA first to map autism-risk genes by function Scientists unravel how mutations disrupt fetal brain's development Pity the poor autism researcher. Recent studies have linked hundreds of gene mutations scattered throughout ...

New link between obesity and diabetes found

2013-11-21
New link between obesity and diabetes found Targeting a single enzyme that raises both sugar and insulin levels in the obese could prevent and treat diabetes NEW YORK, NY (November 21, 2013) –A single overactive enzyme worsens the two core defects ...

Researchers identify genomic variant associated with sun sensitivity, freckles

2013-11-21
Researchers identify genomic variant associated with sun sensitivity, freckles NIH-funded work finds genetic switch for pigmentation trait in non-coding, regulatory region of newly associated gene Researchers have identified a genomic ...

The company you keep shapes what you learn

2013-11-21
The company you keep shapes what you learn Research from Universities of Leicester, Sussex and Cambridge into desert locusts discovers how your environment shapes your thinking A team of scientists has shown how the environment shapes learning and memory by ...

Growth more stunted in lower-income youth with kidney disease

2013-11-21
Growth more stunted in lower-income youth with kidney disease NIH-funded study suggests increasing treatment adherence may help Even with more prescriptions for growth hormone, children and adolescents with chronic ...

Targets of anticancer drugs have broader functions than what their name suggests

2013-11-21
Targets of anticancer drugs have broader functions than what their name suggests Findings have implications for oncology, diabetes drug development PHILADELPHIA - Drugs that inhibit the activity of enzymes called histone deacetylases ...

2 human proteins found to affect how 'jumping gene' gets around

2013-11-21
2 human proteins found to affect how 'jumping gene' gets around Using a new method to catch elusive "jumping genes" in the act, researchers have found two human proteins that are used by one type of DNA to replicate itself and move from place to place. The discovery, ...

Follow the genes: Yale team finds clues to origin of autism

2013-11-21
Follow the genes: Yale team finds clues to origin of autism Finding major new clues to the origins of autism, a Yale-led team of researchers has pinpointed which cell types and regions of the developing human brain are affected by gene mutations linked to autism. ...

UT Dallas study: Initial success for new tinnitus treatment

2013-11-21
UT Dallas study: Initial success for new tinnitus treatment UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants ...

Intestinal bacteria influence food transit through the gut

2013-11-21
Intestinal bacteria influence food transit through the gut Food transit through the small intestine affects the body's absorption of nutrients and, consequently, our health. The discovery that food transit time is regulated by a hormone indicates new ways to ...

LAST 30 PRESS RELEASES:

Cognitive decline comes sooner for people with heart failure

SMEs’ ability to innovate is strongly tied to the learning and decision-making skills of managers

Researchers recycle wind turbine blade materials to make improved plastics

Low neighborhood walkability is associated with increased risk of cardiovascular disease

Common phrases, not fancy words, make you sound more fluent in a foreign language

Printed skin to replace animal testing

Precision medicine could be possible in the fight against antibiotic resistance

Researchers at the Lewis Katz School of Medicine at Temple University identify new targeted approach to protect neurons against degeneration

Western diet causes inflammation, traditional African food protects

Electrochemical method supports nitrogen circular economy

How researchers are shining a light on kidney disease

Some gut bacteria could make certain drugs less effective

PEPITEM sequence shows effects in psoriasis, comparable to steroid cream

Older teens who start vaping post-high school risk rapid progress to frequent use

Corpse flowers are threatened by spotty recordkeeping

Riding the AI wave toward rapid, precise ocean simulations

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

[Press-News.org] Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses
First line anti-viral protein rendered ineffective by Amphotericin B